Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Adenocarcinoma
>>
Amgen
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
Neupogen
(filgrastim) / Kyowa Kirin, Amgen
Vectibix
(panitumumab) / Amgen
Neulasta
(pegfilgrastim) / Roche
Stivarga
(regorafenib) / Bayer
rilotumumab
(AMG 102) / Amgen
Prolia
(denosumab) / Amgen